Paweł Kaliński

18.4k total citations · 3 hit papers
186 papers, 14.1k citations indexed

About

Paweł Kaliński is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Paweł Kaliński has authored 186 papers receiving a total of 14.1k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Immunology, 90 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Paweł Kaliński's work include Immunotherapy and Immune Responses (108 papers), Cancer Immunotherapy and Biomarkers (61 papers) and T-cell and B-cell Immunology (53 papers). Paweł Kaliński is often cited by papers focused on Immunotherapy and Immune Responses (108 papers), Cancer Immunotherapy and Biomarkers (61 papers) and T-cell and B-cell Immunology (53 papers). Paweł Kaliński collaborates with scholars based in United States, Netherlands and Japan. Paweł Kaliński's co-authors include Martien L. Kapsenberg, Catharien M. U. Hilkens, Eddy A. Wierenga, Ravikumar Muthuswamy, Joost H. N. Schuitemaker, Nataša Obermajer, Esther C. de Jong, Pedro L. Vieira, Robert P. Edwards and Robbie B. Mailliard and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Paweł Kaliński

175 papers receiving 13.8k citations

Hit Papers

Regulation of Immune Responses by Prostaglan... 1997 2026 2006 2016 2011 1999 1997 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Regulation of Immune Responses by Prostaglandin E2
    2011 1.2k citations Paweł Kaliński The Journal of Immunology profile →
  2. T-cell priming by type-1and type-2 polarized dendritic cells: the concept of a third signal
    1999 737 citations Paweł Kaliński, Catharien M. U. Hilkens et al. profile →
  3. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells
    1997 506 citations Paweł Kaliński, Catharien M. U. Hilkens et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paweł Kaliński United States 60 9.9k 4.6k 3.0k 1.3k 791 186 14.1k
Wenda Gao United States 40 10.7k 1.1× 2.6k 0.6× 2.1k 0.7× 925 0.7× 1.3k 1.7× 95 15.1k
Stephanie S. Watowich United States 52 9.6k 1.0× 3.6k 0.8× 3.5k 1.2× 952 0.7× 1.0k 1.3× 126 14.5k
Eugene Maraskovsky Australia 61 11.7k 1.2× 3.9k 0.9× 5.0k 1.7× 643 0.5× 1.0k 1.3× 127 16.4k
Roza Nurieva United States 43 14.3k 1.4× 3.1k 0.7× 2.4k 0.8× 1.2k 0.9× 1.1k 1.4× 76 17.5k
Sofie Struyf Belgium 67 6.0k 0.6× 5.5k 1.2× 4.2k 1.4× 676 0.5× 1.0k 1.3× 207 13.9k
Yuka Kanno United States 59 11.4k 1.2× 3.9k 0.9× 4.3k 1.5× 1.2k 0.9× 1.1k 1.4× 97 17.3k
Dieter Kabelitz Germany 68 10.8k 1.1× 3.8k 0.8× 4.0k 1.3× 689 0.5× 1.5k 1.8× 379 15.8k
Jason D. Fontenot United States 23 14.3k 1.5× 2.5k 0.6× 2.0k 0.7× 1.4k 1.1× 1.3k 1.6× 39 17.0k
Serge Lebecque France 59 15.0k 1.5× 4.2k 0.9× 3.8k 1.3× 671 0.5× 1.5k 1.9× 123 19.5k
Xiaojing Ma United States 47 5.2k 0.5× 2.5k 0.5× 2.4k 0.8× 730 0.6× 1.2k 1.5× 143 9.3k

Countries citing papers authored by Paweł Kaliński

Since Specialization
Citations

This map shows the geographic impact of Paweł Kaliński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Kaliński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Kaliński more than expected).

Fields of papers citing papers by Paweł Kaliński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paweł Kaliński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Kaliński. The network helps show where Paweł Kaliński may publish in the future.

Co-authorship network of co-authors of Paweł Kaliński

This figure shows the co-authorship network connecting the top 25 collaborators of Paweł Kaliński. A scholar is included among the top collaborators of Paweł Kaliński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paweł Kaliński. Paweł Kaliński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roy, Arya Mariam, Ankita Kapoor, Kristopher Attwood, et al.. (2024). Real-world efficacy and adverse events of neoadjuvant immunotherapy in patients with early-stage triple-negative breast cancer: A multi-center experience.. Journal of Clinical Oncology. 42(16_suppl). e23293–e23293.
2.
Gandhi, Shipra, Mateusz Opyrchal, Kristopher Attwood, et al.. (2024). Abstract PO1-18-03: Chemokine-modulating regimen (rintatolimod, IFN-α2b, celecoxib): New strategy to drive CD8+T-cells into triple negative breast cancer. Cancer Research. 84(9_Supplement). PO1–18. 1 indexed citations
3.
Dong, Bowen, Nataša Obermajer, Takemasa Tsuji, et al.. (2024). NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer Immunology Research. 12(10). 1421–1437. 3 indexed citations
4.
Gandhi, Shipra, Mateusz Opyrchal, Melissa Grimm, et al.. (2023). Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx. Journal for ImmunoTherapy of Cancer. 11(11). e007381–e007381. 10 indexed citations
5.
Roy, Arya Mariam, Ashish Gupta, Kazuaki Takabe, et al.. (2022). Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?. Cancers. 14(8). 1856–1856. 17 indexed citations
6.
Kaliński, Paweł, Claire F. Verschraegen, Steven K. Clinton, et al.. (2020). 156P High TLR3 expression predicts improved survival in patients with clear cell renal cell carcinoma. Annals of Oncology. 31. S301–S301.
7.
Mahalingam, Devalingam, Grey Wilkinson, Kevin H. Eng, et al.. (2019). Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study. Clinical Cancer Research. 26(1). 71–81. 142 indexed citations
8.
Theodoraki, Marie‐Nicole, Saigopalakrishna S. Yerneni, Saumendra N. Sarkar, et al.. (2018). Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment. Cancer Research. 78(15). 4292–4302. 28 indexed citations
9.
Wong, Jeffrey L., Nataša Obermajer, Kunle Odunsi, Robert P. Edwards, & Paweł Kaliński. (2016). Synergistic COX2 Induction by IFNγ and TNFα Self-Limits Type-1 Immunity in the Human Tumor Microenvironment. Cancer Immunology Research. 4(4). 303–311. 51 indexed citations
10.
Wong, Jeffrey L., Erik Berk, Robert P. Edwards, & Paweł Kaliński. (2013). IL-18–Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment. Cancer Research. 73(15). 4653–4662. 125 indexed citations
11.
Obermajer, Nataša, Jeffrey L. Wong, Robert P. Edwards, et al.. (2013). Induction and stability of human Th17 cells require endogenous NOS2 and cGMP-dependent NO signaling. The Journal of Experimental Medicine. 210(7). 1433–1445. 93 indexed citations
12.
Kirkwood, John M., Lisa H. Butterfield, Ahmad A. Tarhini, et al.. (2012). Immunotherapy of cancer in 2012. CA A Cancer Journal for Clinicians. 62(5). 309–335. 345 indexed citations
13.
Muthuswamy, Ravikumar, Erik Berk, Herbert J. Zeh, et al.. (2012). NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells. Cancer Research. 72(15). 3735–3743. 112 indexed citations
14.
Obermajer, Nataša, Ravikumar Muthuswamy, Kunle Odunsi, Robert P. Edwards, & Paweł Kaliński. (2011). PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment. Cancer Research. 71(24). 7463–7470. 377 indexed citations
15.
Umemura, Naoki, Jianzhong Zhu, Yvonne K. Mburu, et al.. (2011). Defective NF-κB Signaling in Metastatic Head and Neck Cancer Cells Leads to Enhanced Apoptosis by Double-Stranded RNA. Cancer Research. 72(1). 45–55. 29 indexed citations
16.
Yang, Deok‐Hwan, Mi‐Hyun Kim, Cheol Yi Hong, et al.. (2010). Alpha-type 1-polarized dendritic cells loaded with apoptotic allogeneic myeloma cell line induce strong CTL responses against autologous myeloma cells. Annals of Hematology. 89(8). 795–801. 21 indexed citations
17.
Fujita, Mitsugu, Xinmei Zhu, Ryo Ueda, et al.. (2009). Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells—Significant Roles of CXCL10. Cancer Research. 69(4). 1587–1595. 84 indexed citations
18.
Muthuswamy, Ravikumar, Julie Urban, Je‐Jung Lee, et al.. (2008). Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation. Cancer Research. 68(14). 5972–5978. 129 indexed citations
19.
Kapsenberg, Martien L., et al.. (2000). Atopic Allergy: A Failure of Antigen-Presenting Cells to Properly Polarize Helper T Cells?. American Journal of Respiratory and Critical Care Medicine. 162(Supplement_2). S76–S80. 12 indexed citations
20.
Kaliński, Paweł, Hermelijn H. Smits, Joost H. N. Schuitemaker, et al.. (2000). IL-4 Is a Mediator of IL-12p70 Induction by Human Th2 Cells: Reversal of Polarized Th2 Phenotype by Dendritic Cells. The Journal of Immunology. 165(4). 1877–1881. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenda Gao Breakdown of academic impact, for papers by Stephanie S. Watowich Breakdown of academic impact, for papers by Eugene Maraskovsky Breakdown of academic impact, for papers by Roza Nurieva Breakdown of academic impact, for papers by Sofie Struyf Breakdown of academic impact, for papers by Yuka Kanno Breakdown of academic impact, for papers by Dieter Kabelitz Breakdown of academic impact, for papers by Jason D. Fontenot Breakdown of academic impact, for papers by Serge Lebecque Breakdown of academic impact, for papers by Xiaojing Ma
Rankless by CCL
2026